Acinetobacter baumannii displays inverse relationship between meropenem resistance and biofilm production

Journal of Chemotherapy

Volumn 27, Issue 1, 2015, Pages 13-15

  Rodrigues Perez, Leandro Reus ^a  

^a HOSPITAL MÃE DE DEUS   (Brazil)

Author keywords

Acinetobacter; Biofilm; Carbapenem; Oxacillinases

Indexed keywords

CIPROFLOXACIN; MEROPENEM; SULTAMICILLIN; ANTIINFECTIVE AGENT; THIENAMYCIN DERIVATIVE;

ACINETOBACTER BAUMANNII; ANTIBIOTIC SENSITIVITY; ARTICLE; ASSAY; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BIOFILM; DISK DIFFUSION; MODIFIED HODGE TEST ASSAY; NONHUMAN; OPTICAL DENSITY; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDY; ACINETOBACTER INFECTION; CROSS INFECTION; DRUG EFFECTS; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTIDRUG RESISTANCE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; BIOFILMS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; THIENAMYCINS;

EID: 84920516913     PISSN: 1120009X     EISSN: 19739478     Source Type: Journal    
DOI: 10.1179/1973947813Y.0000000159     Document Type: Article

References (21)

1. Dijkshoorn L, Nemec A, Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol. 2007;5:939–51.
2. Vidal R, Dominguez M, Urrutia H, Bello H, Gonzalez G, Garcia A, et al. Biofilm formation by Acinetobacter baumannii. Microbios. 1996;86:49–58.
3. Stoodley P, Sauer K, Davies DG, Costerton JW. Biofilms as complex differentiated communities. Annu Rev Microbiol. 2002;56:187–209.
4. Rodríguez-Baño J, Martí S, Soto S, Fernández-Cuenca F, Cisneros JM, Pachón J, et al. Biofilm formation in Acinetobacter baumannii: associated features and clinical implications. Clin Microbiol Infect. 2008;14:276–8.
5. Sanchez CJ Jr, Mende K, Beckius ML, Akers KS, Romano DR, Wenke JC, et al. Biofilm formation by clinical isolates and the implications in chronic infections. BMC Infect Dis. 2013;13:47.
6. Lee JC, Koerten H, van den Broek P, Beekhuizen H, Wolterbeek R, van den Barselaar M, et al. Adherence of Acinetobacter baumannii strains to human bronchial epithelial cells. Res Microbiol. 2006;157:360–6.
7. Schreckenberger PC, Daneshvar MI, Weyant RS, Hollis DG. Acinetobacter, Achromobacter, Chryseobacterium, Moraxella, and other nonfermentative Gram-negative rods. In: Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH, editors. Manual of clinical microbiology, 8th edn. Washington, DC: American Society of Microbiology; 2003. p. 749–79.
8. Arakawa Y, Shibata N, Shibayama K, Kurokawa H, Yagi T, Fujiwara H, et al. Convenient test for screening metallo-beta-lactamase-producing Gram-negative bacteria by using thiol compounds. J Clin Microbiol. 2002;38:40–3.
9. Picão RC, Andrade SS, Nicoletti AG, Campana EH, Moraes GC, Mendes RE, et al. Metallo-b-lactamase detection: comparative evaluation of double-disk synergy versus combined disk tests for IMP-, GIM-, SIM-, SPM-, or VIM-producing isolates. J Clin Microbiol. 2008;46:2028–37.
10. Higgins PG, Lehmann M, Seifert H. Inclusion of OXA-143 primers in a multiplex polymerase chain reaction (PCR) for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents. 2010;12:305–14.
11. Perez LR, Antunes AL, Freitas AL, Barth AL. When the resistance gets clingy: Pseudomonas aeruginosa harboring metallo-b-lactamase gene shows high ability to produce biofilm. Eur J Clin Microbiol Infect Dis. 2012;31:711–4.
12. Tomaras AP, Dorsey CW, Edelmann RE, Actis LA. Attachment to and biofilm formation on abiotic surfaces by Acinetobacter baumannii: involvement of a novel chaperoneusher pili assembly system. Microbiology. 2003;149:3473–84.
13. Vahaboglu H, Coskunkan F, Tansel O, Ozturk R, Sahin N, Koksal I, et al. Clinical importance of extended-spectrum blactamase (PER-1 type)-producing Acinetobacter spp. and Pseudomonas aeruginosa strains. J Med Microbiol. 2001;50:642–5.
14. Sechi LA, Karadenizli A, Deriu A, Zanetti S, Kolayli F, Balikci E, et al. PER-1 type beta-lactamase production in Acinetobacter baumannii is related to cell adhesion. Med Sci Monit. 2004;10:180–4.
15. Wroblewska MM, Towner KJ, Marchel H, Luczak M. Emergence and spread of carbapenem-resistant strains of Acinetobacter baumannii in a tertiary care hospital in Poland. Clin Microbiol Infect. 2007;13:490–6.
16. James GA, Korber DR, Caldwell DE, Costerton JW. Digital image analysis of growth and starvation responses of a surfacecolonizing Acinetobacter spp. J Bacteriol. 1995;177:907–15.
17. Inglis TJ, Lim TM, Ng ML, Tang EK, Hui KP. Structural features of tracheal tube biofilm formed during prolonged mechanical ventilation. Chest. 1995;108:1049–52.
18. Hoffman LR, D’Argenio DA, MacCoss MJ, Zhang Z, Jones RA, Miller SI. Aminoglycoside antibiotics induce bacterial biofilm formation. Nature. 2005;436:1171–5.
19. Gallant CV, Daniels C, Leung JM, Ghosh AS, Young KD, Kotra LP, et al. Common beta-lactamases inhibit bacterial biofilm formation. Mol Microbiol. 2005;58:1012–24.
20. Pozzi C, Waters EM, Rudkin JK, Schaeffer CR, Lohan AJ, Tong P, et al. Methicillin resistance alters the biofilm phenotype and attenuates virulence in Staphylococcus aureus deviceassociated infections. PLoS Pathog. 2012;8:e1002626.
21. Nucleo E, Steffanoni L, Fugazza G, Migliavacca R, Giacobone E, Navarra A, et al. Growth in glucose-based medium and exposure to subinhibitory concentrations of imipenem induce biofilm formation in a multidrug-resistant clinical isolate of Acinetobacter baumannii. BMC Microbiol. 2009;9:270.